MedTrace Logo

Virtual Reality and White Noise During Peripheral IV Catheterization in Adults

NCT07241988 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2026-03-24

No results posted yet for this study

Summary

This randomized controlled study aims to examine the effects of using virtual reality glasses and white noise during peripheral intravenous catheterization on pain, anxiety, and satisfaction in adult patients. Participants will be randomly assigned to one of three groups: virtual reality, white noise, or control. Pain and anxiety levels will be assessed using standardized scales immediately after the procedure, and satisfaction will be evaluated following the intervention. The study aims to determine whether these non-pharmacological methods can reduce pain and anxiety and increase patient satisfaction during intravenous catheterization.

Conditions

  • Peripheral Intravenous Catheterization
  • Pain
  • Anxiety
  • Patient Satisfaction

Interventions

BEHAVIORAL

Virtual Reality Glasses

Participants in this group will wear virtual reality glasses displaying calming nature scenes accompanied by ambient sounds during peripheral intravenous catheterization. The intervention will begin three minutes before the procedure and continue until completion. This visual distraction technique is intended to reduce pain perception and anxiety levels and to increase patient satisfaction during the procedure.

BEHAVIORAL

White Noise (Rain Sound)

Participants will listen to natural white noise, specifically the sound of rain, through headphones during peripheral intravenous catheterization. The sound will begin three minutes before the procedure and continue until completion. This auditory distraction technique is intended to reduce pain perception and anxiety levels and to increase patient satisfaction during the procedure.

Sponsors & Collaborators

  • Gizem Göktuna

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-11
Primary Completion
2026-01-30
Completion
2026-01-30

Countries

  • Turkey (Türkiye)

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07241988 on ClinicalTrials.gov